Skip to main content
Top
Published in: Current Urology Reports 4/2014

01-04-2014 | Female Urology (K Kobashi, Section Editor)

Urgency After a Sling: Review of the Management

Authors: Nitya Abraham, Sandip Vasavada

Published in: Current Urology Reports | Issue 4/2014

Login to get access

Abstract

Urinary urgency after synthetic sling surgery may be persistent urgency that preceded the surgery or de novo urgency that developed after surgery. Recent studies estimate a 40 % rate of persistent urgency after synthetic sling surgery in women with mixed urinary incontinence. Causes of de novo urgency after synthetic sling surgery include postoperative urinary tract infection (7.4–17.4 %), bladder outlet obstruction (1.9–19.7 %), perforation of the urinary tract (0.5–5 %), and idiopathic urgency (0–28 %). Given the temporal relationship of de novo urgency developing after surgery, until proven otherwise, one should assume that the etiology is obstruction. Evaluation includes a history and physical exam, urinalysis, and post-void residual. Cystoscopy and urodynamics may help rule out surgical complications. Management is based on the etiology of the urgency. Urinary tract perforation and bladder outlet obstruction are treated with surgical intervention. Idiopathic de novo or persistent urgency after synthetic sling surgery are treated similarly to idiopathic overactive bladder, with behavioral therapy as first-line treatment, antimuscarinics or beta-agonists as second-line therapy, and intravesical onabotulinumtoxinA or sacral neuromodulation as third-line therapy.
Literature
1.••
go back to reference Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20. This is the primary reference for current terminology with regard to voiding and pelvic floor dysfunction. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20. This is the primary reference for current terminology with regard to voiding and pelvic floor dysfunction.
2.
go back to reference Dmochowski RR, Blaivas JM, Gormley EA, et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010;183(5):1906–14. Dmochowski RR, Blaivas JM, Gormley EA, et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010;183(5):1906–14.
3.
go back to reference Katsumi HK, Rutman MP. Can we predict if overactive bladder symptoms will resolve after sling surgery in women with mixed urinary incontinence? Curr Urol Rep. 2010;11(5):328–37. Katsumi HK, Rutman MP. Can we predict if overactive bladder symptoms will resolve after sling surgery in women with mixed urinary incontinence? Curr Urol Rep. 2010;11(5):328–37.
4.•
go back to reference Albo ME, Litman HJ, Richter HE, et al. Treatment success of retropubic and transobturator mid urethral slings at 24 months. J Urol. 2012;188(6):2281–7. This is a prospective randomized controlled trial comparing outcomes of retropubic and transobturator mid-urethral slings in women with stress predominant urinary incontinence, with results at 24 months presented. Albo ME, Litman HJ, Richter HE, et al. Treatment success of retropubic and transobturator mid urethral slings at 24 months. J Urol. 2012;188(6):2281–7. This is a prospective randomized controlled trial comparing outcomes of retropubic and transobturator mid-urethral slings in women with stress predominant urinary incontinence, with results at 24 months presented.
5.••
go back to reference Lee JK, Dwyer PL, Rosamilia A, et al. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis. BJOG. 2011;118(7):798–805. This is a large retrospective cohort study of 1225 women with stress urinary incontinence and urgency or urgency incontinence, who underwent mid-urethral sling placement. With a mean follow-up of 4 years, rates of persistent urgency and urgency incontinence were assessed, as well as factors associated with persistent urgency and or incontinence. Lee JK, Dwyer PL, Rosamilia A, et al. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis. BJOG. 2011;118(7):798–805. This is a large retrospective cohort study of 1225 women with stress urinary incontinence and urgency or urgency incontinence, who underwent mid-urethral sling placement. With a mean follow-up of 4 years, rates of persistent urgency and urgency incontinence were assessed, as well as factors associated with persistent urgency and or incontinence.
7.
go back to reference Swartz M, Ching C, Gill B, et al. Risk of infection after midurethral synthetic sling surgery: are postoperative antibiotics necessary? Urology. 2010;75(6):1305–8. Swartz M, Ching C, Gill B, et al. Risk of infection after midurethral synthetic sling surgery: are postoperative antibiotics necessary? Urology. 2010;75(6):1305–8.
8.
go back to reference Anger JT, Litwin MS, Wang Q, et al. Complications of sling surgery among female Medicare beneficiaries. Obstet Gynecol. 2007;109:707.PubMedCrossRef Anger JT, Litwin MS, Wang Q, et al. Complications of sling surgery among female Medicare beneficiaries. Obstet Gynecol. 2007;109:707.PubMedCrossRef
9.
go back to reference Lluel P, Duquenne C, Martin D. Experimental bladder instability following bladder outlet obstruction in the female rat. J Urol. 1998;160:2253.PubMedCrossRef Lluel P, Duquenne C, Martin D. Experimental bladder instability following bladder outlet obstruction in the female rat. J Urol. 1998;160:2253.PubMedCrossRef
10.
go back to reference Appell R. Guideline for the surgical management of female SUI 2009 Update. Appell R. Guideline for the surgical management of female SUI 2009 Update.
11.
go back to reference Daneshgari F, Kong W, Swartz M. Complications of mid urethral slings: important outcomes for future clinical trials. J Urol. 2008;180:1890.PubMedCrossRef Daneshgari F, Kong W, Swartz M. Complications of mid urethral slings: important outcomes for future clinical trials. J Urol. 2008;180:1890.PubMedCrossRef
12.
go back to reference Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;3629(22):2066–76. Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;3629(22):2066–76.
13.
go back to reference Lee JK, Dwyer PL, Rosamilia A, et al. Which women develop urgency or urgency urinary incontinence following midurethral slings? Int Urogynecol J. 2013;24(1):47–54. Lee JK, Dwyer PL, Rosamilia A, et al. Which women develop urgency or urgency urinary incontinence following midurethral slings? Int Urogynecol J. 2013;24(1):47–54.
14.
go back to reference Sajadi KP, Vasavada SP. Overactive bladder after sling surgery. Curr Urol Rep. 2013;11(6):366–71. Sajadi KP, Vasavada SP. Overactive bladder after sling surgery. Curr Urol Rep. 2013;11(6):366–71.
15.
go back to reference Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn. 2000;19:553.PubMedCrossRef Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn. 2000;19:553.PubMedCrossRef
16.
go back to reference Groutz A, Blaivas JG, Chaikin DC. Bladder outlet obstruction in women: definition and characteristics. Neurourol Urodyn. 2000;19:213.PubMedCrossRef Groutz A, Blaivas JG, Chaikin DC. Bladder outlet obstruction in women: definition and characteristics. Neurourol Urodyn. 2000;19:213.PubMedCrossRef
17.
go back to reference Rodrigues P, Hering F, Dias EC. Female obstruction after incontinence surgery may present different urodynamic patterns. Int Urogynecol J. 2013;24(2):331–6. Rodrigues P, Hering F, Dias EC. Female obstruction after incontinence surgery may present different urodynamic patterns. Int Urogynecol J. 2013;24(2):331–6.
18.
go back to reference Starkman JS, Duffy III JW, Wolter CE, et al. The evolution of obstruction induced overactive bladder symptoms following urethrolysis for female bladder outlet obstruction. J Urol. 2008;179:1018.PubMedCrossRef Starkman JS, Duffy III JW, Wolter CE, et al. The evolution of obstruction induced overactive bladder symptoms following urethrolysis for female bladder outlet obstruction. J Urol. 2008;179:1018.PubMedCrossRef
19.•
go back to reference Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188(6):2455–63. These guidelines detail the evaluation for overactive bladder and the various treatment options available. Note that beta-agonists and botulinum toxin were approved by the FDA for idiopathic overactive bladder after the publication of these guidelines. Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188(6):2455–63. These guidelines detail the evaluation for overactive bladder and the various treatment options available. Note that beta-agonists and botulinum toxin were approved by the FDA for idiopathic overactive bladder after the publication of these guidelines.
20.
go back to reference Yoo EH, Kim D. Predictors of postoperative antimuscarinics in women with mixed urinary incontinence after transobturator surgery. Int Urogynecol J. 2013;24(3):401–6. Yoo EH, Kim D. Predictors of postoperative antimuscarinics in women with mixed urinary incontinence after transobturator surgery. Int Urogynecol J. 2013;24(3):401–6.
21.
go back to reference Opar A. Overactive bladder, under scrutiny, gets a new treatment. Nat Med. 2012;18(8):1159. Opar A. Overactive bladder, under scrutiny, gets a new treatment. Nat Med. 2012;18(8):1159.
22.••
go back to reference Dmochowski R, Chapple C, Nitti VW, et al. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol. 2010;184(6):2416–22. This important randomized controlled trial demonstrates the efficacy of botulinum toxin for idiopathic overactive bladder. Dmochowski R, Chapple C, Nitti VW, et al. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol. 2010;184(6):2416–22. This important randomized controlled trial demonstrates the efficacy of botulinum toxin for idiopathic overactive bladder.
23.
go back to reference Full Prescribing Information for OnabotulinumtoxinA. Full Prescribing Information for OnabotulinumtoxinA.
24.
go back to reference Sherman ND, Jamison MG, Webster GD, et al. Sacral neuromodulation for the treatment of refractory urinary urge incontinence after stress incontinence surgery. Am J Obstet Gynecol. 2005;193:2083.PubMedCrossRef Sherman ND, Jamison MG, Webster GD, et al. Sacral neuromodulation for the treatment of refractory urinary urge incontinence after stress incontinence surgery. Am J Obstet Gynecol. 2005;193:2083.PubMedCrossRef
25.••
go back to reference Starkman JS, Duffy JW III, Wolter CE, et al. Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulation. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:277. This is the only study in the literature that assessed sacral neuromodulation for refractory overactive bladder after urethrolysis. Starkman JS, Duffy JW III, Wolter CE, et al. Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulation. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:277. This is the only study in the literature that assessed sacral neuromodulation for refractory overactive bladder after urethrolysis.
Metadata
Title
Urgency After a Sling: Review of the Management
Authors
Nitya Abraham
Sandip Vasavada
Publication date
01-04-2014
Publisher
Springer US
Published in
Current Urology Reports / Issue 4/2014
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-014-0400-y

Other articles of this Issue 4/2014

Current Urology Reports 4/2014 Go to the issue

New Imaging Techniques (A Atala and A Rastinehad, Section Editors)

Imaging and Interventional Therapy for Varicoceles

Urothelial Cancer (A Sagalowsky, Section Editor)

Narrow-Band Imaging Evaluation of Bladder Tumors